Compile Data Set for Download or QSAR
Report error Found 221 Enz. Inhib. hit(s) with all data for entry = 13248
TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771210(US12414952, Example 1.15)
Affinity DataIC50: 0.100nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771286(US12414952, Example 4.9)
Affinity DataIC50: 0.200nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771211(US12414952, Example 1.16)
Affinity DataIC50: 0.300nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771301(US12414952, Example 10.3)
Affinity DataIC50: 0.400nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771299(US12414952, Example 9.7)
Affinity DataIC50: 0.5nMAssay Description:Method (B): Measurement of A2a Binding Affinity Using SPABinding affinity using SPA was conducted as follows. Test compounds (50 nL) were dispensed i...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771297(US12414952, Example 7.6)
Affinity DataIC50: 0.5nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771319(US12414952, Example 17.14)
Affinity DataIC50: 0.5nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771300(US12414952, Example 9.8)
Affinity DataIC50: 0.600nMAssay Description:Method (B): Measurement of A2a Binding Affinity Using SPABinding affinity using SPA was conducted as follows. Test compounds (50 nL) were dispensed i...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771311(US12414952, Example 17.7)
Affinity DataIC50: 0.600nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771315(US12414952, Example 17.10)
Affinity DataIC50: 0.600nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771323(US12414952, Example 17.18)
Affinity DataIC50: 0.600nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771258(US12414952, Example 3.24)
Affinity DataIC50: 0.700nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771287(US12414952, Example 4.10)
Affinity DataIC50: 0.700nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771312(US12414952, Example 17.8-1)
Affinity DataIC50: 0.700nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771318(US12414952, Example 17.13)
Affinity DataIC50: 0.700nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771235(US12414952, Example 2.24)
Affinity DataIC50: 0.900nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771208(US12414952, Example 1.13)
Affinity DataIC50: 1nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771238(US12414952, Example 3.4)
Affinity DataIC50: 1.10nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771321(US12414952, Example 17.16)
Affinity DataIC50: 1.20nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771294(US12414952, Example 6.8)
Affinity DataIC50: 1.20nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2b(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771286(US12414952, Example 4.9)
Affinity DataIC50: 1.20nMAssay Description:The reported affinity of the compounds of the invention for the human A2b adenosine receptor was determined experimentally using a radioligand filtra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771317(US12414952, Example 17.12)
Affinity DataIC50: 1.20nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771198(US12414952, Example 1.3)
Affinity DataIC50: 1.30nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771212(US12414952, Example 1.17)
Affinity DataIC50: 1.30nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771316(US12414952, Example 17.11)
Affinity DataIC50: 1.30nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771298(US12414952, Example 8.4)
Affinity DataIC50: 1.30nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771259(US12414952, Example 3.25)
Affinity DataIC50: 1.60nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771215(US12414952, Example 2.4)
Affinity DataIC50: 1.60nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771292(US12414952, Example 6.6)
Affinity DataIC50: 1.90nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771205(US12414952, Example 1.10)
Affinity DataIC50: 2.10nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771320(US12414952, Example 17.15)
Affinity DataIC50: 2.20nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771239(US12414952, Example 3.5)
Affinity DataIC50: 2.20nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771218(US12414952, Example 2.7)
Affinity DataIC50: 2.20nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771227(US12414952, Example 2.16)
Affinity DataIC50: 2.30nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771313(US12414952, Example 17.8-2)
Affinity DataIC50: 2.30nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2b(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771258(US12414952, Example 3.24)
Affinity DataIC50: 2.40nMAssay Description:The reported affinity of the compounds of the invention for the human A2b adenosine receptor was determined experimentally using a radioligand filtra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771203(US12414952, Example 1.8)
Affinity DataIC50: 2.40nMAssay Description:Method (B): Measurement of A2a Binding Affinity Using SPABinding affinity using SPA was conducted as follows. Test compounds (50 nL) were dispensed i...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771260(US12414952, Example 3.26)
Affinity DataIC50: 2.5nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2b(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771297(US12414952, Example 7.6)
Affinity DataIC50: 2.60nMAssay Description:The reported affinity of the compounds of the invention for the human A2b adenosine receptor was determined experimentally using a radioligand filtra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771257(US12414952, Example 3.23)
Affinity DataIC50: 2.70nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2b(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771260(US12414952, Example 3.26)
Affinity DataIC50: 2.70nMAssay Description:The reported affinity of the compounds of the invention for the human A2b adenosine receptor was determined experimentally using a radioligand filtra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771262(US12414952, Example 3.28)
Affinity DataIC50: 2.90nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771324(US12414952, Example 17.19)
Affinity DataIC50: 3nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771334(US12414952, Example 20.4)
Affinity DataIC50: 3.20nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771199(US12414952, Example 1.4)
Affinity DataIC50: 3.60nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771206(US12414952, Example 1.11)
Affinity DataIC50: 3.60nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771263(US12414952, Example 3.29)
Affinity DataIC50: 4nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771314(US12414952, Example 17.9)
Affinity DataIC50: 4.10nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771307(US12414952, Example 17.3)
Affinity DataIC50: 4.20nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM771280(US12414952, Example 3.46)
Affinity DataIC50: 4.40nMAssay Description:Method (A): Measurement of A2a Binding Affinity Using Radioligand Binding148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL co...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/28/2025
Entry Details
US Patent

Displayed 1 to 50 (of 221 total ) | Next | Last >>
Jump to: